Evergreen Sustainable Enterprises, Inc. (EGSE)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0006 (-75.00%)
At close: Jul 7, 2025
Intra-Cellular Therapies Market Cap
EGSE has a market cap or net worth of $24.36 thousand as of August 1, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
24.36K
Enterprise Value
n/a
Revenue
2.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 29, 2019, EGSE's market cap has decreased from 337.02K to 24.36K, a decrease of -92.77%. That is a compound annual growth rate of -37.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 24.36K | -60.00% |
| Dec 29, 2023 | 60.91K | -99.81% |
| Dec 30, 2022 | 32.26M | -56.15% |
| Dec 31, 2021 | 73.58M | 1,244.00% |
| Dec 31, 2020 | 5.47M | -40.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |